Back to Results
Loading ...
Meet Rachel J. Buchsbaum, MD
Title(s)
Director of the Cancer Center; Chief, Division of Hematology/Oncology; Hematologist/Oncologist, Breast Health Center; Fellowship Program Director, Tufts Medical Center; Dr. Jane F. Desforges, MD, Chair in Hematology/Oncology and Professor of Medicine, Tufts University School of Medicine; Professor of Genetics, Graduate School of Biomedical Sciences, Tufts University School of Medicine
Department + Services
Medicine, Hematology/Oncology
Clinical Focus Areas
Breast cancer therapy, risk assessment and prevention
Seeing Patients In
Boston, 617-636-5757
Request Appointment
| Programs + Specialties |
|
| Training + Education |
Cornell University Medical College; Beth Israel Deaconess Medical Center; Tufts Medical Center
|
| Board Certifications |
Hematology, Internal Medicine, Oncology |
| NPI # |
1255360640 |
| Gender |
Female |
| Accepted Insurances |
View Accepted Insurances at Tufts Medical Center
|
Tufts Medical Center
South Building, 7th Floor
800 Washington St.
Box 245
Boston, MA 02111
Phone #: 617-636-5757
Fax #: 617-636-2342
|
2021, "Top Doctor", Boston Magazine
2020, "Top Doctor," Boston Magazine
2018/2019, "Top Doctor," Boston Magazine
2017 "Top Doctor", Boston Magazine
Milton O. and Natalie V. Zucker Clinical Teaching Prize for Innovation in Medical Education, Tufts University School of Medicine
Outstanding Lecturer, Tufts University School of Medicine
Faculty of 1000, Cell Signalling Section
Diane Connolly-Zaniboni Scholar in Breast Cancer Research
Top Doctor, US News and World Report
Castle Connolly, Exceptional Women in Medicine
I became interested in cancer research during medical school and residency. During my early fellowship training in Hematology and Oncology I explored the biology of B and T lymphocytes and the role of cytotoxic T lymphocytes in murine models of EBV-associated lymphoproliferative disease. I subsequently became interested in using the molecular biology of signal transduction to investigate pathways underlying cancer cell invasion and metastasis. My laboratory joined the Molecular Oncology Research Institute in 2003 and transitioned to the Division of Hematology/Oncology in 2017. We are exploring the role of the tumor microenvironment in breast cancer biology, with a specific focus on how intra-cellular and inter-cellular signaling pathways are affected in the co-evolution of breast cancer and the breast cancer microenvironment. A major aim is translating our findings in the laboratory to the development of prognostic, predictive, and therapeutic tools for the treatment of patients with breast cancer.
